The Beauty Health Company has filed an amendment to its previously issued Form 8-K, providing additional details regarding the departure of Marla Beck as CEO, President, and director effective September 30, 2025. The amendment includes the executed Separation Agreement and General Release of all Claims between the company and Ms. Beck.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Beauty Health Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-045385), on October 17, 2025, and is solely responsible for the information contained therein.
Comments